EGFR Inhibitor,
879127-07-8,
CHEMBL387187,
Cyclopropanecarboxylic acid-(3-(6-(3-trifluoromethyl-phenylamino)-pyrimidin-4-ylamino)-phenyl)-amide,
N-(3-((6-((3-(Trifluoromethyl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)cyclopropanecarboxamide,
K00598a,
N-{3-[(6-{[3-(trifluoromethyl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}cyclopropanecarboxamide,
EGFR Inhibitor 324674,
SCHEMBL242230,
GTPL5963,
CTK8E9808,
DTXSID40429554,
HMS3229E03,
BDBM50200394,
ZINC13831337,
API0010446,
CCG-206749,
EGFR Inhibitor [879127-07-8],
NCGC00167954-01,
RT-012452,
4-[3-(Trifluoromethyl)anilino]-6-[3-(cyclopropylcarbonylamino)anilino]pyrimidine,
N-(3-(6-(3-(trifluoromethyl)phenylamino)pyrimidin-4-ylamino)phenyl)cyclopropanecarboxamide,
N-3-6-3-trifluoromethyl)phenylamino)pyrimidin-4-ylamino)phenyl)cyclopropanecarboxamide,
CyclopropanecarboxaMide,N-[3-[[6-[[3-(trifluoroMethyl)phenyl]aMino]-4-pyriMidinyl]aMino]phenyl]-,
Cyclopropanecarboxylic acid (3-(6-(3-trifluoromethyl-phenylamino)-pyrimidin-4-ylamino)-phenyl)-amide,
D03BJB,
CID9549299,
A13673,
EGFR Inhibitor [879127-07-8] - EGFR Inhibitor 324674,